Drug wars: how big pharma raises prices and keeps generics off the market
While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frond...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge
Cambridge University Press
2017
|
| Schlagworte: | |
| Online-Zugang: | BSB01 Volltext |
| Zusammenfassung: | While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs |
| Beschreibung: | Title from publisher's bibliographic system (viewed on 17 Jul 2017) |
| Beschreibung: | 1 online resource (xii, 151 pages) |
| ISBN: | 9781316717424 |
| DOI: | 10.1017/9781316717424 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044537557 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 171013s2017 |||| o||u| ||||||eng d | ||
| 020 | |a 9781316717424 |9 978-1-316-71742-4 | ||
| 024 | 7 | |a 10.1017/9781316717424 |2 doi | |
| 035 | |a (ZDB-20-CBO)CR9781316717424 | ||
| 035 | |a (OCoLC)1011380992 | ||
| 035 | |a (DE-599)BVBBV044537557 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 082 | 0 | |a 338.4/76151 | |
| 100 | 1 | |a Feldman, Robin |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Drug wars |b how big pharma raises prices and keeps generics off the market |c Robin Feldman, Evan Frondorf |
| 264 | 1 | |a Cambridge |b Cambridge University Press |c 2017 | |
| 300 | |a 1 online resource (xii, 151 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Title from publisher's bibliographic system (viewed on 17 Jul 2017) | ||
| 505 | 8 | |a Machine generated contents note: Introduction: big scandals, higher prices; 1. The winding road to generic entry; 2. 'Generation 1.0': the rise and fall of traditional pay-for-delay; 3. 'Generation 2.0': complicating pay-for-delay; 4. 'Generation 3.0': new tactics for active obstruction of generics; 5. 'Generation 3.0' continued: obstruction of regulatory pathways; 6. Empirical evidence of a citizen's pathway gone astray; Conclusion: a call for systematic reform | |
| 520 | |a While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs | ||
| 650 | 4 | |a Recht | |
| 650 | 4 | |a Drugs / Prices / United States | |
| 650 | 4 | |a Drugs / Law and legislation / United States | |
| 650 | 4 | |a Pharmaceutical policy / United States | |
| 650 | 4 | |a Pharmaceutical industry / United States | |
| 650 | 4 | |a Generic drugs / United States | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Frondorf, Evan |e Verfasser |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, hardback |z 978-1-107-16848-0 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/9781316717424 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-20-CBO | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029936697 | ||
| 966 | e | |u https://doi.org/10.1017/9781316717424 |l BSB01 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804177893690966016 |
|---|---|
| any_adam_object | |
| author | Feldman, Robin Frondorf, Evan |
| author_facet | Feldman, Robin Frondorf, Evan |
| author_role | aut aut |
| author_sort | Feldman, Robin |
| author_variant | r f rf e f ef |
| building | Verbundindex |
| bvnumber | BV044537557 |
| collection | ZDB-20-CBO |
| contents | Machine generated contents note: Introduction: big scandals, higher prices; 1. The winding road to generic entry; 2. 'Generation 1.0': the rise and fall of traditional pay-for-delay; 3. 'Generation 2.0': complicating pay-for-delay; 4. 'Generation 3.0': new tactics for active obstruction of generics; 5. 'Generation 3.0' continued: obstruction of regulatory pathways; 6. Empirical evidence of a citizen's pathway gone astray; Conclusion: a call for systematic reform |
| ctrlnum | (ZDB-20-CBO)CR9781316717424 (OCoLC)1011380992 (DE-599)BVBBV044537557 |
| dewey-full | 338.4/76151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/76151 |
| dewey-search | 338.4/76151 |
| dewey-sort | 3338.4 576151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| doi_str_mv | 10.1017/9781316717424 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03040nmm a2200469zc 4500</leader><controlfield tag="001">BV044537557</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">171013s2017 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781316717424</subfield><subfield code="9">978-1-316-71742-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/9781316717424</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9781316717424</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1011380992</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044537557</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/76151</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Feldman, Robin</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug wars</subfield><subfield code="b">how big pharma raises prices and keeps generics off the market</subfield><subfield code="c">Robin Feldman, Evan Frondorf</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xii, 151 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from publisher's bibliographic system (viewed on 17 Jul 2017)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Machine generated contents note: Introduction: big scandals, higher prices; 1. The winding road to generic entry; 2. 'Generation 1.0': the rise and fall of traditional pay-for-delay; 3. 'Generation 2.0': complicating pay-for-delay; 4. 'Generation 3.0': new tactics for active obstruction of generics; 5. 'Generation 3.0' continued: obstruction of regulatory pathways; 6. Empirical evidence of a citizen's pathway gone astray; Conclusion: a call for systematic reform</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Prices / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Law and legislation / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Generic drugs / United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Frondorf, Evan</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, hardback</subfield><subfield code="z">978-1-107-16848-0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/9781316717424</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029936697</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/9781316717424</subfield><subfield code="l">BSB01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV044537557 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:55:19Z |
| institution | BVB |
| isbn | 9781316717424 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029936697 |
| oclc_num | 1011380992 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | 1 online resource (xii, 151 pages) |
| psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| publisher | Cambridge University Press |
| record_format | marc |
| spelling | Feldman, Robin Verfasser aut Drug wars how big pharma raises prices and keeps generics off the market Robin Feldman, Evan Frondorf Cambridge Cambridge University Press 2017 1 online resource (xii, 151 pages) txt rdacontent c rdamedia cr rdacarrier Title from publisher's bibliographic system (viewed on 17 Jul 2017) Machine generated contents note: Introduction: big scandals, higher prices; 1. The winding road to generic entry; 2. 'Generation 1.0': the rise and fall of traditional pay-for-delay; 3. 'Generation 2.0': complicating pay-for-delay; 4. 'Generation 3.0': new tactics for active obstruction of generics; 5. 'Generation 3.0' continued: obstruction of regulatory pathways; 6. Empirical evidence of a citizen's pathway gone astray; Conclusion: a call for systematic reform While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs Recht Drugs / Prices / United States Drugs / Law and legislation / United States Pharmaceutical policy / United States Pharmaceutical industry / United States Generic drugs / United States USA Frondorf, Evan Verfasser aut Erscheint auch als Druck-Ausgabe, hardback 978-1-107-16848-0 https://doi.org/10.1017/9781316717424 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Feldman, Robin Frondorf, Evan Drug wars how big pharma raises prices and keeps generics off the market Machine generated contents note: Introduction: big scandals, higher prices; 1. The winding road to generic entry; 2. 'Generation 1.0': the rise and fall of traditional pay-for-delay; 3. 'Generation 2.0': complicating pay-for-delay; 4. 'Generation 3.0': new tactics for active obstruction of generics; 5. 'Generation 3.0' continued: obstruction of regulatory pathways; 6. Empirical evidence of a citizen's pathway gone astray; Conclusion: a call for systematic reform Recht Drugs / Prices / United States Drugs / Law and legislation / United States Pharmaceutical policy / United States Pharmaceutical industry / United States Generic drugs / United States |
| title | Drug wars how big pharma raises prices and keeps generics off the market |
| title_auth | Drug wars how big pharma raises prices and keeps generics off the market |
| title_exact_search | Drug wars how big pharma raises prices and keeps generics off the market |
| title_full | Drug wars how big pharma raises prices and keeps generics off the market Robin Feldman, Evan Frondorf |
| title_fullStr | Drug wars how big pharma raises prices and keeps generics off the market Robin Feldman, Evan Frondorf |
| title_full_unstemmed | Drug wars how big pharma raises prices and keeps generics off the market Robin Feldman, Evan Frondorf |
| title_short | Drug wars |
| title_sort | drug wars how big pharma raises prices and keeps generics off the market |
| title_sub | how big pharma raises prices and keeps generics off the market |
| topic | Recht Drugs / Prices / United States Drugs / Law and legislation / United States Pharmaceutical policy / United States Pharmaceutical industry / United States Generic drugs / United States |
| topic_facet | Recht Drugs / Prices / United States Drugs / Law and legislation / United States Pharmaceutical policy / United States Pharmaceutical industry / United States Generic drugs / United States USA |
| url | https://doi.org/10.1017/9781316717424 |
| work_keys_str_mv | AT feldmanrobin drugwarshowbigpharmaraisespricesandkeepsgenericsoffthemarket AT frondorfevan drugwarshowbigpharmaraisespricesandkeepsgenericsoffthemarket |